How should a 34-year-old woman with diabetes and a glycated hemoglobin (A1C) of 6.5% who is planning pregnancy be managed pre-conception?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of 34-Year-Old Woman with A1C 6.5% Planning Pregnancy

This patient should delay conception until her A1C is optimized to <6.5% (ideally <6%), use effective contraception during this optimization period, and begin intensive preconception management immediately to reduce the risk of congenital anomalies, spontaneous abortion, and other pregnancy complications. 1

Immediate Actions

Contraception Until Metabolic Optimization

  • Prescribe effective contraception immediately and continue until glycemic targets are achieved 1, 2
  • Consider long-acting reversible contraception for highest efficacy 2
  • An A1C of 6.5% places her at the threshold where risk of congenital anomalies begins to rise significantly above baseline 1

Glycemic Target Before Conception

  • Target A1C <6.5% (ideally <6%) before attempting pregnancy to minimize risk of congenital anomalies (anencephaly, microcephaly, congenital heart disease, caudal regression) 1
  • Epidemiological data show that A1C values up to 1% above normal are associated with malformation rates similar to non-diabetic pregnancies, but rates continue to decrease with lower A1C levels 1
  • Her current A1C of 6.5% is at the upper acceptable limit; achieving <6% would provide the lowest risk 1

Comprehensive Preconception Evaluation

Medication Review and Adjustment

  • Immediately discontinue potentially teratogenic medications: ACE inhibitors, ARBs, statins 1
  • Transition to insulin if not already using it, as insulin is the preferred agent with established safety data for pregnancy 2
  • If currently on oral agents or GLP-1 receptor agonists, transition to insulin before conception 2

Laboratory Assessment

  • Thyroid-stimulating hormone (especially important in type 1 diabetes) 1
  • Serum creatinine and urine albumin-to-creatinine ratio 1
  • Baseline A1C (already obtained at 6.5%) 1

Screening for Diabetic Complications

  • Ophthalmology referral for baseline retinopathy screening 1
  • Assess for nephropathy, hypertension, and cardiovascular disease 1
  • Evaluate for autonomic and peripheral neuropathy 1

Infectious Disease and Routine Screening

  • Rubella immunity, rapid plasma reagin, hepatitis B, HIV testing 1
  • Pap smear and cervical cultures 1
  • Blood typing 1

Nutritional Supplementation

  • Prescribe prenatal vitamins with at least 400 mcg folic acid (or 4-5 mg if BMI >35) 1, 2
  • Begin immediately, as neural tube closure occurs by 28 days post-conception 1

Intensive Diabetes Management Program

Self-Management Skills Required

  • Implement frequent self-monitoring of blood glucose (preprandial and postprandial) 1
  • Establish appropriate meal planning with registered dietitian 1
  • Master insulin self-administration and dose adjustment 1
  • Learn hypoglycemia recognition and treatment (patient and family members) 1
  • Incorporate regular physical activity 1

Multidisciplinary Team Approach

  • Refer to multidisciplinary preconception care team including endocrinology/diabetology, maternal-fetal medicine specialist, diabetes educators (nurse and dietitian), and social worker 1, 2
  • This team-based approach has been shown to reduce congenital malformations from 10.9% to 1.2% and spontaneous abortions from 24% to 7% 3, 4

Counseling on Pregnancy Risks

Maternal and Fetal Risks of Suboptimal Control

  • Congenital anomalies (anencephaly, microcephaly, congenital heart disease, caudal regression) increase directly with A1C elevation 1, 5
  • Spontaneous abortion risk is substantially elevated with uncontrolled diabetes 1, 5
  • Preeclampsia, macrosomia, intrauterine fetal demise, neonatal hypoglycemia, and neonatal hyperbilirubinemia 1, 5
  • Long-term offspring risk of obesity and type 2 diabetes 1

Evidence for Preconception Care Benefits

  • Women who achieve optimal glycemic control before conception have dramatically better outcomes: 1.2% vs 10.9% major malformation rate and 7% vs 24% spontaneous abortion rate compared to those who present already pregnant 3, 4
  • These benefits occur despite increased hypoglycemia during intensive management (median 2.7 episodes per week), which was not associated with excess malformations 4

Timeline and Follow-Up

Before Attempting Conception

  • Achieve and maintain A1C <6.5% (ideally <6%) for at least 2-3 months 1
  • Complete all screening evaluations and medication adjustments 1
  • Ensure patient has mastered intensive insulin management skills 1

Common Pitfall to Avoid

  • Do not allow conception attempts until glycemic optimization is achieved, as 61% of diabetic women still enter pregnancy with suboptimal control despite being under medical care 6
  • Women not specifically advised to achieve target A1C levels before pregnancy are significantly more likely to conceive with suboptimal control 6

Once Pregnant

  • A1C target during pregnancy becomes <6% (even lower than preconception) due to altered red blood cell turnover 1
  • Intensive glucose monitoring with targets: premeal/bedtime/overnight 60-99 mg/dL, peak postprandial 100-129 mg/dL 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Preconception Care for Patients Using GLP-1 Receptor Agonists

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Early Screening and Management of Pre‑Diabetes in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.